Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
The World Medical Association is now debating the next
revision of the Declaration of Helsinki. Kenneth Rothman and Karin Michels argue that critics of the declaration, notably the US Food and
Drug Administration, are trying to give scientists greater latitude
than the declaration allows. In particular, Rothman and Michels dispute
the morality of performing placebo controlled trials when there is an
existing accepted treatment, and they offer other suggestions to
strengthen the protection of patients who participate in medical
experiments. Michael Baum argues against their absolutism on this issue
and against what he considers their anti-science stance
Kenneth J Rothman a Department of Epidemiology and Biostatistics,
Boston University School of Public Health, Boston University Medical
Center, Boston, MA 02118-2526, USA, b Harvard Medical School Obstetrics and
Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston,
MA 02115, USA
Correspondence to K J Rothman KRothman@bu.edu
Actions that penalise some for the good of others are
defended under the utilitarian banner of doing the greatest good
for the greatest number. For this reason we justify imposing quarantine to prevent the spread of infectious illness. In the same spirit some
scientists and regulators would ask patients who participate in medical
Read all Rapid Responses